Kolexia
D'Agostino Maria Antonietta Rhumatologie
D'Agostino Maria Antonietta
Rhumatologie
Hôpital Ambroise Paré
Boulogne-Billancourt, France
271 Activités
72 Followers
Scientifique
Digital
Production scientifique
Activités par an
Expertise
Sujets de recherche
{{person.topmesh1.name}} Arthrite Polyarthrite rhumatoïde Synovite Rhumatismes Arthrite psoriasique Spondylarthrite Inflammation Arthrose Psoriasis

Collaborateurs

Voir plus
Joulin-Jousse Sandrine
Joulin-Jousse Sandrine
Hôpital Cavale Blanche, Brest, France
Breban Maxime
Breban Maxime
Hôpital Ambroise Paré, Boulogne-Billancourt, France
Dougados Maxime
Dougados Maxime
Hôpital Cochin, Paris, France
Aegerter Philippe
Aegerter Philippe
Hôpital Ambroise Paré, Boulogne-Billancourt, France

Industries

Voir plus
Abbvie
11 collaboration(s)
Dernière en 2021
Novartis
11 collaboration(s)
Dernière en 2022
Janssen
6 collaboration(s)
Dernière en 2020
Sanofi
1 collaboration(s)
Dernière en 2020

Dernières activités

Voir plus
Defining domains: developing consensus-based definitions for foundational domains in OMERACT core outcome sets.
Seminars in arthritis and rheumatism   29 février 2024
New onset of guttate psoriasis, Hallopeau's continuous acrodermatitis, and psoriatic arthritis after COVID-19 vaccine.
Scandinavian journal of rheumatology   26 février 2024
Risk of cardiovascular disease decreases over time in psoriatic arthritis but not in spondylarthritis: meta-analysis of longitudinal studies.
Rheumatology (Oxford, England)   16 février 2024
Abatacept inhibits inflammation and onset of rheumatoid arthritis in individuals at high risk (ARIAA): a randomised, international, multicentre, double-blind, placebo-controlled trial.
Lancet (London, England)   13 février 2024
Intensive training programme for ultrasound-guided minimally invasive synovial tissue biopsy on knees and wrists in different phases of inflammation.
RMD open   13 février 2024
Abatacept in individuals at high risk of rheumatoid arthritis (APIPPRA): a randomised, double-blind, multicentre, parallel, placebo-controlled, phase 2b clinical trial.
Lancet (London, England)   13 février 2024
2023 EULAR recommendations on imaging in diagnosis and management of crystal-induced arthropathies in clinical practice.
Annals of the rheumatic diseases   06 février 2024
Standardization of interstitial lung disease assessment by ultrasound: results from a Delphi process and web-reliability exercise by the OMERACT ultrasound working group.
Seminars in arthritis and rheumatism   05 février 2024
Evolving and evaluating the OMERACT fellows program: insights and implications from OMERACT 2023 fellows.
Seminars in arthritis and rheumatism   04 février 2024
Comment on: Prevalence of ultrasound and clinical findings suggestive of inflammatory arthritis in children with skin psoriasis. Reply.
Rheumatology (Oxford, England)   01 février 2024